ARTICLE | Company News
With established foothold in Japan, Amgen takes over JV from Astellas
January 23, 2020 9:04 PM UTC
Amgen will take over full ownership of the 2013 JV it launched with Astellas in Japan but the two will continue to co-promote Amgen’s three drugs in the country. The U.S. biotech has used its experience with Astellas to get its commercial footing in the region as it looks to launch other drugs there in the future.
On Thursday, Amgen Inc. (NASDAQ:AMGN) said that it would purchase the 49% of shares owned by Astellas Pharma Inc. (Tokyo:4503) for an undisclosed sum. Effective April 1, the JV will become a wholly-owned Amgen affiliate...